Evidence map›Paper›PMID 38559279›Full record

ArticlebioRxiv : the preprint server for biology2024

Development and application of GlycanDIA workflow for glycomic analysis.

Yixuan Xie, Xingyu Liu, Chenfeng Zhao, Siyu Chen, Shunyang Wang, Zongtao Lin, Faith M Robison, Benson M George, Ryan A Flynn, Carlito B Lebrilla and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Yixuan XieDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States.ORCID 0000-0002-8512-6053
Xingyu LiuDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States.ORCID 0000-0003-0008-7815
Chenfeng ZhaoDepartment of Computer Science & Engineering, Washington University, St. Louis, Missouri, United States.
Siyu ChenDepartment of Chemistry, University of California, Davis, Davis, California, United States.ORCID 0009-0003-9584-6905
Shunyang WangDepartment of Chemistry, University of California, Davis, Davis, California, United States.ORCID 0000-0001-9851-2968
Zongtao LinDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States.ORCID 0000-0002-6017-338X
Faith M RobisonDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States.
Benson M GeorgeStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, United States.ORCID 0000-0003-4031-0954
Ryan A FlynnStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, United States.ORCID 0000-0001-5013-0442
Carlito B LebrillaDepartment of Chemistry, University of California, Davis, Davis, California, United States.
Benjamin A GarciaDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States.ORCID 0000-0003-3596-4750

Funding

Shared Resources Core 2: Quantitative Proteomics CoreP01CA196539 · NCI · ROCKEFELLER UNIVERSITY · PI YOUNG, MICHAEL WARREN · 2015 to 2024
$17.6M
The incorporation of human milk oligosaccharides in brain glycoconjugatesR01GM049077 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI LEBRILLA, CARLITO B · 1999 to 2024
$6.3M
Viral modulation of epitranscriptomic mechanismsR01AI118891 · NIAID · WASHINGTON UNIVERSITY · PI GARCIA, BENJAMIN A, WEITZMAN, MATTHEW D. · 2015 to 2025
$5.4M
Comprehensive Characterization of Glycosylation Alterations in Alzheimer’s DiseaseR01AG062240 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JIN, LEE-WAY, LEBRILLA, CARLITO B · 2018 to 2022
$3.3M
Quantitative mass spectrometry for comprehending epigenetic mechanisms in a new underlying neurological developmental disorderR01HD106051 · NICHD · WASHINGTON UNIVERSITY · PI Benjamin A Garcia · 2022 to 2026
$2.6M
NCI NIH HHS P01 CA196539NIAID NIH HHS R01 AI118891NIA NIH HHS R01 AG062240NICHD NIH HHS R01 HD106051NIGMS NIH HHS R01 GM049077
6 · The paper itself

Abstract

Glycans modify protein, lipid, and even RNA molecules to form the regulatory outer coat on cells called the glycocalyx. The changes in glycosylation have been linked to the initiation and progression of many diseases. Thus, while the significance of glycosylation is well established, a lack of accessible methods to characterize glycans has hindered the ability to understand their biological functions. Mass spectrometry (MS)-based methods have generally been at the core of most glycan profiling efforts; however, modern data-independent acquisition (DIA), which could increase sensitivity and simplify workflows, has not been benchmarked for analyzing glycans. Herein, we developed a DIA-based glycomic workflow, termed GlycanDIA, to identify and quantify glycans with high sensitivity and accuracy. The GlycanDIA workflow combined higher energy collisional dissociation (HCD)-MS/MS and staggered windows for glycomic analysis, which facilitates the sensitivity in identification and the accuracy in quantification compared to conventional data-dependent acquisition (DDA)-based glycomics. To facilitate its use, we also developed a generic search engine, GlycanDIA Finder, incorporating an iterative decoy searching for confident glycan identification and quantification from DIA data. The results showed that GlycanDIA can distinguish glycan composition and isomers from

Identifiers

PMID38559279
PMCPMC10980037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.